Richter entered into an asset purchase agreement with Mycenax for the biosimilar tocilizumab

About
About Us

Headquartered in Hungary and founded in 1901, Gedeon Richter Plc. is an innovation- driven specialty pharmaceutical company. The activities of the Hungarian-directed multinational company are vertically integrated and involve pharmaceutical manufacturing, research and development, sales and marketing.
Specialty pharma transformation

The strategic goal of Gedeon Richter is to become a prominent player in the league of European-based midpharma.
Areas of Expertise
Areas of Expertise

Gedeon Richter aims to offer high added value products with a strategy firmly grounded in original research, women's healthcare and biosimilars.
At the forefront of innovation

The research of new chemical entities has always been of paramount importance to Richter’s corporate strategy. Richter’s R&D base, which employs more than 1,200 people, makes the company the most important pharmaceutical research centre in Central Eastern Europe.
Our Products
Our Products

Richter manufactures more than 200 drugs including original, generic and licensed products which provide effective, modern and reasonably priced treatments in almost every therapeutic area. The company focuses on developing and manufacturing central nervous system, cardiovascular and gynaecological products.
Wide range of therapies for women

With in-house active ingredient manufacturing and a comprehensive product portfolio, Richter offers an innovative therapeutic solution for every age group and condition.
Sustainability
Sustainability

Long-term thinking and continuous innovation are stable building blocks of Gedeon Richter’s history. We believe that we should meet the needs of the present in such a way that future generations can turn to us with confidence.
Strong corporate culture

Our human resources form the basis on which our continuous business success and organic growth can be built. We are proud that the Richter name stands not only for innovative products, but also a stable and friendly workplace.

Gedeon Richter Investors Announcements Richter entered into an asset purchase agreement with Mycenax for the biosimilar tocilizumab

29/04/2020

Business related Acquisition Biotechnology PARTNER - MYCENAX API - TOCILIZUMAB

20200429_EN_BUS_BIOTECH_ACQ_MYCENAX_TOCILIZUMAB

43 kb 29/04/2020 pdf

Necessary

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Necessary cookies
Name	Provider	Purpose	Expiry	Type
ARRAffinity	www.gedeonrichter.com	Used to distribute traffic to the website on several servers in order to optimise response times.	Session	HTTP Cookie
ASP.NET_SessionId	www.gedeonrichter.com	Preserves the visitor's session state across page requests.	Session	HTTP Cookie
CookieConsentStatement	www.gedeonrichter.com	Stores the user's cookie consent state for the current domain.	1 year(s)	HTTP Cookie
FacebookCookieStatement	www.gedeonrichter.com	Stores whether the user has accepted the Facebook related cookies for the current domain or not.	1 year(s)	HTTP Cookie
GoogleAnalyticsCookieStatement	www.gedeonrichter.com	Stores whether the user has accepted the Google Analytics related cookies for the current domain or not.	1 year(s)	HTTP Cookie
hq#lang	www.gedeonrichter.com	Stores the language preference.	Session	HTTP Cookie
GPS	YouTube	Registers a unique ID on mobile devices to enable tracking based on geographical GPS location.	1 day(s)	HTTP Cookie
VISITOR_INFO1_LIVE	YouTube	Tries to estimate the users' bandwidth on pages with integrated YouTube videos.	179 day(s)	HTTP Cookie
YSC	YouTube	Registers a unique ID to keep statistics of what videos from YouTube the user has seen.	Session	HTTP Cookie

Statistics

Statistic cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.

Statistics cookies
Name	Provider	Purpose	Expiry	Type
_ga	www.gedeonrichter.com	Registers a unique ID that is used to generate statistical data on how the visitor uses the website.	2 year(s)	HTTP Cookie
_gat	www.gedeonrichter.com	Used by Google Analytics to throttle request rate.	1 day(s)	HTTP Cookie
_gid	www.gedeonrichter.com	Registers a unique ID that is used to generate statistical data on how the visitor uses the website.	1 day(s)	HTTP Cookie

Marketing

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Marketing cookies
Name	Provider	Purpose	Expiry	Type
fr	Facebook	Used by Facebook to deliver a series of advertisement products such as real time bidding from third party advertisers.	3 month(s)	HTTP Cookie

Manage cookies
Purpose and Content	Expiry	On/Off
Google Tag Manager: Google Tag Manager is a platform for code management. By saving cookies on your computer, we can evaluate the user behavior on our websites. The tool does not collect any personal data, but triggers tags from other providers, which might collect data. Google Tag Manager does not access this data.	24 month(s)	Google Tag Manager On Off
Facebook: Facebook delivers a series of advertisement products such as real time bidding from third party advertisers.	12 month(s)	Facebook On Off